Sponsors

Congenital infection assay panel

Abbott Diagnostics has developed a panel of congenital assays for its popular Architect platform. These assays can be used for the detection of human cytomegalovirus (CMV), Toxoplasma gondii and rubella virus.

The Toxoplasma IgG assay has now been launched in the UK, with IgM and avidity assays to follow. Rubella and CMV IgG and IgM assays are already available, and CMV avidity is due for launch soon.

While other avidity assays remove low-avidity antibodies by washing, the new Architect AVIcomp technology removes the high-avidity antibodies selectively and detects low-avidity antibodies directly for improved diagnosis of acute or recurrent infection.

www.abbottdiagnostics.co.uk

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024